Please try another search
We aim to achieve a long term growth of your capital by investing in shares of a limited number of attractive companies operating in the healthcare sector, worldwide. We particularly focus on large and medium size companies which account for at least 75% of our investments. Smaller size companies may represent up to 25% of the investments. We take investment decisions on the basis of a thorough analysis of healthcare sector companies' revenues, earnings, profit margins and other data. This analysis is combined with an evaluation of financial markets through the identification of global trends in the pharmaceutical, medical technology, biotechnology and medical service sectors. It allows us to build a concentrated portfolio of companies of which we have a detailed knowledge and we intimately know to represent the most promising investment opportunities on the long term. We may freely select the investments we make across all possible opportunities.
Name | Title | Since | Until |
---|---|---|---|
Ulf Arvidsson | - | 2004 | Now |
Mikael Svensson | - | 2003 | Now |
Angelica Fatouros | - | 1999 | 2019 |
Biography | The fund is managed by the fundamental unit within the Equities team, with Angelica Fatouros as lead portfolio manager. The Stockholm-based team has long, solid experience of fundamental equity management. |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review